How to read a research peptide Certificate of Analysis — what each test means and what to look for
A Certificate of Analysis (CoA) is the document that translates "99% purity" from marketing claim into verifiable evidence. Most research peptide buyers never read the CoA — and most vendors know this. This guide explains what each test on a peptide CoA measures, what the numbers should look like for a credible result, and what red flags should make you reject a vendor. Pairs with the [PeptideGuide methodology page](/research/how-peptideguide-rates-vendors-2026) — the methodology axes weight testing depth heavily, and this guide teaches you to apply the same evaluation yourself.
What a CoA is and is not: a Certificate of Analysis is a document issued by an analytical chemistry lab reporting the measured properties of a specific batch of product. A genuine CoA names the lab, names the specific batch (lot number), states the test methods used, reports numerical results, and is signed/dated by the analyst. A document that says "99% purity, lab tested" without naming the lab, the lot, the methods, or the analyst is a marketing claim, not a CoA. The first credibility check on any vendor CoA: does it identify all four (lab name + lot number + methods + analyst signature)?
In-house CoA vs independent third-party CoA: vendors can either run their own analytical testing (in-house) OR send samples to an independent third-party analytical chemistry lab. In-house CoAs have a structural conflict-of-interest — the vendor is reporting test results on its own product, with no external check. Third-party CoAs (Janoshik Analytical in Slovakia is the segment's most-cited independent lab; other names include Eurofins, SGS, Intertek) remove the conflict. Independent blind multi-lab testing — where the vendor sends batches to a third-party lab WITHOUT disclosing vendor identity — is the gold standard. PeptideGuide methodology weights testing depth based on this hierarchy: 10/10 requires independent blind multi-lab; 5/10 caps in-house-only CoA regardless of how many tests are reported.
HPLC (High-Performance Liquid Chromatography) — the purity test: HPLC separates a peptide sample into its component chemicals and quantifies the percentage of the desired peptide vs impurities. A credible HPLC report shows: (1) a chromatogram with clear peaks separated by retention time, (2) a single dominant peak identified as the target peptide with peak-area percentage stated, (3) smaller impurity peaks quantified, (4) total purity reported as area-percentage. Red flag: a CoA that reports "HPLC: 99%" without showing the chromatogram is providing only the conclusion, not the evidence. Reputable labs always include the chromatogram image. For BPC-157, TB-500, GHK-Cu, and similar research peptides, credible HPLC results land at 98.5-99.5% purity.
LC-MS (Liquid Chromatography Mass Spectrometry) — the identity test: LC-MS confirms that the molecule being sold is actually the peptide it claims to be. The instrument measures the molecular mass to 4+ decimal places — every peptide has a unique theoretical molecular mass calculable from its amino acid sequence. A credible LC-MS report shows: (1) a mass spectrum with the dominant peak at the expected mass, (2) the measured mass within ±0.001 Da of theoretical, (3) often the M+1 isotope peak as identity confirmation. Without LC-MS, you have only HPLC purity — purity of WHAT is unverified. A vendor that publishes HPLC but not LC-MS may be selling a high-purity wrong-molecule product. Insist on both.
CLND (Chemiluminescent Nitrogen Detection) — the peptide content test: HPLC purity is a percentage of detectable substances. If the sample is 99% pure peptide vs salts/water, the HPLC reports 99% purity. But "1mg" of product might actually contain 0.7mg of peptide and 0.3mg of trifluoroacetic acid (TFA) salt and water. CLND measures absolute peptide content — telling you the actual milligrams of peptide per vial. For research where dosing accuracy matters (most published peptide research), CLND-verified peptide content is the gold standard. CLND is rare in the consumer-facing peptide segment; Particle Peptides (Slovakia, EU 7-parameter CoA) is one of the only vendors publishing CLND results. Pharma Lab Global, SwissChems, Core Peptides do not publish CLND.
LAL / endotoxin test: peptides produced by recombinant or synthetic methods can carry bacterial endotoxin contamination (lipopolysaccharide / LPS). For research peptides intended for injection, endotoxin contamination causes inflammatory responses that confound research results. The Limulus Amebocyte Lysate (LAL) test measures endotoxin in EU/mL — research-grade peptides should be below 0.5 EU/mL. Core Peptides US publishes endotoxin testing as part of its multi-lab CoA structure. Most vendors do not. For injection research, the absence of endotoxin data is a meaningful gap.
FTIR (Fourier Transform Infrared Spectroscopy) — structural confirmation: FTIR measures the infrared absorption spectrum of a molecule, which encodes its chemical functional groups. For peptides, FTIR confirms the peptide backbone structure — amide bonds, side chain functional groups, secondary structure. A correct FTIR spectrum overlaid against the theoretical spectrum for the target peptide structure is the deepest form of identity confirmation, going beyond LC-MS molecular mass to confirm the actual structural arrangement. FTIR is the rarest test in consumer peptide CoAs. Research Peptides Europe (Spain) is the only vendor in PeptideGuide's EU catalog publishing FTIR as a standard protocol.
TAMC / TYMC — microbial counts: Total Aerobic Microbial Count (TAMC) and Total Yeast and Mold Count (TYMC) measure microbial contamination in the final lyophilized peptide powder. For research-grade peptides intended for injection, both should be reported and within acceptable ranges per European Pharmacopoeia or USP standards. The absence of TAMC/TYMC data on a CoA means microbial contamination has not been measured — a gap for injection research, less critical for non-injection research applications.
Heavy metals testing: trace heavy metal contamination (lead, arsenic, mercury, cadmium) can occur during peptide synthesis. The ICH Q3D guideline sets daily limits for elemental impurities in pharmaceutical products. Research peptide CoAs that include heavy metals testing report concentrations in ppm/ppb vs the ICH limit. Most consumer-grade peptide vendors do not publish heavy metals testing. Particle Peptides (7-parameter EU gold standard) and Research Peptides Europe include heavy metals testing; most others do not.
Reading the date and batch lot number: every CoA should reference a specific batch (lot number) and the date the test was performed. A credible vendor maintains a batch-level CoA archive — when you receive product, the lot number on your vial should match a CoA in the archive that was tested no more than 6 months before your purchase. Red flag: a single "demo CoA" shown on the website with no per-batch updates. The vendor is showing one test result and applying it to all subsequent batches, which is misleading — peptide quality varies batch-to-batch and per-batch CoAs are the operational truth.
Red flag checklist — reject any vendor whose CoA shows: (1) No lab name. (2) No lot number. (3) No analyst signature or date. (4) Only HPLC, no LC-MS (purity without identity). (5) Conclusions without chromatograms or mass spectra (claims without evidence). (6) A single demo CoA applied to all batches (no per-batch testing). (7) "Lab tested" without specifying the lab. (8) CoA dated more than 12 months before your purchase (testing aged out). Vendors meeting fewer than 3 of these red flags are credible mid-tier. Vendors meeting zero red flags AND including CLND or FTIR are premium tier.
How to use this guide as a buyer: before ordering from any vendor, find the CoA for the specific product you intend to buy. Check the 4 minimum elements (lab + lot + methods + analyst). Verify both HPLC and LC-MS are included with chromatograms / spectra shown. For injection research, look for endotoxin (LAL) data. For dosing-critical research, look for CLND peptide content. For protocol-grade verification, look for FTIR structural confirmation. The depth of testing you require depends on the depth of your research; PeptideGuide methodology takes the position that "what testing does this vendor publish per batch" is the most reliable quality signal — better than reviews, better than years-in-business, better than affiliate marketing.
✓Pros
- HPLC + LC-MS combination is the minimum credible test pair — purity and identity
- Independent third-party lab CoAs remove vendor conflict-of-interest
- Per-batch CoA archive is the operational truth (peptide quality varies batch-to-batch)
- CLND peptide content data prevents salt-and-water dosing surprises
- LAL endotoxin testing critical for injection research
- FTIR provides structural identity confirmation beyond LC-MS molecular mass
- Heavy metals testing important for pharmaceutical-grade research applications
×Cons
- CLND testing is rare in consumer-facing peptide segment
- FTIR is the rarest test — only Research Peptides Europe publishes it as standard
- Heavy metals testing not published by most consumer vendors
- Per-batch CoA archives require vendor infrastructure many small vendors lack
- Single demo CoA shown on website is a common red flag — buyers must verify per-batch
What is the minimum CoA I should accept from a vendor?
HPLC (purity percentage with chromatogram shown) + LC-MS (identity confirmation via molecular mass with mass spectrum shown), issued by a named lab on a named batch (lot number) with a date within the last 12 months and an analyst signature. Without LC-MS, purity is meaningless because you don't know WHAT was pure. Without the chromatogram or mass spectrum shown, you're reading conclusions not evidence. Without a per-batch lot number, you're reading a demo CoA that may not reflect what's in your vial.
Why does HPLC purity matter less than CLND peptide content?
HPLC purity is a percentage of detectable substances. If your sample is 99% pure peptide vs 1% salts/water by detector signal, HPLC reports 99%. But "1mg" of product might actually contain 0.7mg of peptide and 0.3mg of trifluoroacetic acid (TFA) salt and water. CLND measures absolute peptide content — telling you actual mg of peptide per vial. For research where dosing accuracy matters, CLND is the truth and HPLC alone is misleading. Particle Peptides (Slovakia) is one of few vendors publishing CLND results as standard.
What is Janoshik Analytical and why does it appear so often?
Janoshik Analytical is an independent analytical chemistry lab in Slovakia (EU). It is the most-cited independent third-party CoA lab in the consumer-facing peptide segment because (a) it serves the segment specifically, (b) its pricing is accessible to mid-tier vendors, and (c) it has built a reputation for credible analytical work without vendor capture. Multiple vendors send batches to Janoshik for independent verification — PeptidesDirect, Particle Peptides, several others. A CoA issued by Janoshik is structurally more credible than a vendor in-house CoA because the lab has no relationship to the product's commercial outcomes.
Should I ever accept an in-house CoA?
In-house CoAs are not automatically untrustworthy, but they cannot reach the PeptideGuide methodology Testing axis 6+ score (HPLC + LC-MS independent threshold). Some large vendors (Core Peptides US is the strongest example) supplement in-house CoAs with periodic independent third-party verification on flagship products — this hybrid approach earns higher trust than pure in-house. For new vendors or vendors without third-party verification, in-house CoAs should be cross-checked against independent batch testing (third-party labs accept samples from buyers for $100-200 per test if you want to verify what you received).
How do I verify a CoA is real and not fabricated?
Three checks: (1) the lab named on the CoA must exist and operate the testing service claimed — Janoshik Analytical, Eurofins, SGS, Intertek, and similar are real labs with verifiable web presences and identifiable analyst names. A "lab name" you cannot find online is a red flag. (2) The CoA should be on the lab's letterhead or template, not the vendor's. (3) For high-stakes verification, you can email the lab directly with the lot number — credible labs maintain testing records and will confirm whether they issued the specific CoA. Vendors fabricating CoAs typically do not contact the lab; the verification cycle exposes the fabrication.
What's the difference between batch testing and product testing?
Batch testing means every manufacturing batch is tested independently. The vendor receives a batch from the manufacturer (often a Chinese peptide manufacturer), sends a representative sample to the lab, receives a per-batch CoA tied to the specific lot number, and only ships product from batches where the CoA meets quality thresholds. Product testing means a vendor tests a single batch once and applies the results to all subsequent batches indefinitely. Batch testing is the operational truth — peptide quality varies meaningfully batch-to-batch even from the same manufacturer. PeptideGuide methodology testing axis scores per-batch CoA structure higher than single-product CoAs.
Should I ask vendors for batch-specific CoAs before ordering?
Yes — for orders above $100 USD or for institutional research budgets, requesting the batch-specific CoA for the lot you'll receive is reasonable due diligence. Credible vendors provide it within 24-48h via email; vendors that delay, deflect, or provide only the demo CoA are signaling that batch-level testing is not their operational reality. For institutional researchers, batch-specific CoAs are typically required by procurement protocols and the vendor's willingness to supply them is part of the institutional vendor-vetting process.
More from this region.
Other articles covering this region's vendors, regulatory framework, and research peptides.